CN1090026C - Novel medicine for stopping narcotic taking and preparation process thereof - Google Patents
Novel medicine for stopping narcotic taking and preparation process thereof Download PDFInfo
- Publication number
- CN1090026C CN1090026C CN99115916A CN99115916A CN1090026C CN 1090026 C CN1090026 C CN 1090026C CN 99115916 A CN99115916 A CN 99115916A CN 99115916 A CN99115916 A CN 99115916A CN 1090026 C CN1090026 C CN 1090026C
- Authority
- CN
- China
- Prior art keywords
- extract
- drug
- notopterygium
- detoxification
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
本发明涉及一种利用藏药配制的新型戒毒药物及其制备方法。The invention relates to a novel drug for detoxification prepared with Tibetan medicine and a preparation method thereof.
毒品问题严重地困扰着各国政府,它严重地威胁人类的健康与社会安全。The drug problem is seriously perplexing the governments of various countries, and it seriously threatens human health and social security.
戒毒问题实际是一个包括脱瘾、康复、心理治疗、社区控制以及完备的医疗保健等领域的系统工程。就治疗的药物而言,主要有两大类组成,即阿片类药物和非阿片类药物。属于前一类的主要以德国首先合成的美沙酮,它是一种成瘾性较小的阿片受体激动剂,可以口服,作用时间较长。属于第二类的有可乐宁和福康片,可减轻海洛因成瘾者的戒断症状。但中医药戒毒处于初期探索阶段,真正能够很好地控制戒断症状的中药制剂和方法,尚未见到。The problem of drug rehabilitation is actually a systematic project including the fields of addiction withdrawal, rehabilitation, psychotherapy, community control and complete medical care. In terms of drugs for treatment, there are two main categories, namely opioid drugs and non-opioid drugs. Methadone, which belongs to the former category, is firstly synthesized in Germany. It is a less addictive opioid receptor agonist that can be taken orally and has a longer duration of action. In the second category are Clonidine and Fukang Tablets, which relieve withdrawal symptoms in heroin addicts. However, Chinese medicine detoxification is still in the initial stage of exploration, and the traditional Chinese medicine preparations and methods that can really control withdrawal symptoms well have not yet been seen.
现代医学认为,吸毒的病理基础是受体学说,戒断症主要表现在中枢和周围的胆缄能受体的兴奋。吗啡类药物成瘾,主要是外源性吗啡样物质与机体吗啡受体结合致内源性吗啡样物质减少或机体吗啡受体耐量增大所致。以往认为吗啡样物质是通过中枢神经系统而发挥作用,最新研究表明,除中枢作用外,吗啡样物质对外周传入神经也有相当的作用。这就是成瘾者不但有极度焦虑等精神症状,还有相当重的躯体症状,如卡他症、关节痛、肌痛、寒颤等症状。Modern medicine believes that the pathological basis of drug abuse is the receptor theory, and withdrawal symptoms are mainly manifested in the excitation of central and peripheral biliary receptors. Morphine drug addiction is mainly caused by the combination of exogenous morphine-like substances and the body's morphine receptors, resulting in the reduction of endogenous morphine-like substances or the increase of the body's morphine receptor tolerance. In the past, it was believed that morphine-like substances exert their effects through the central nervous system. The latest research shows that, in addition to central effects, morphine-like substances also have considerable effects on peripheral afferent nerves. This means that addicts not only have mental symptoms such as extreme anxiety, but also have quite serious physical symptoms, such as catarrh, joint pain, myalgia, chills and other symptoms.
本发明的目的是为了提供一种有效物质可与吗啡受体立体性结合,通过其具有抗胆碱和抗组胺等作用,使中枢和外周症状消除,达到控制戒断症状,不形成新的依赖性、快效、安全、治疗有效率达100%的新型戒毒药物。The object of the present invention is to provide a kind of active substance that can be combined stereoscopically with morphine receptors, through which it has anticholinergic and antihistamine effects, so that central and peripheral symptoms can be eliminated, so as to control withdrawal symptoms without forming new Dependence, fast-acting, safe, and 100% effective treatment of new drug detoxification drugs.
本发明的目的还在于提供一种新型戒毒药物的制备方法。The object of the present invention is also to provide a preparation method of a novel detoxification drug.
本发明的另一目的是为了提供一种避免成瘾者服药后的呕吐、药物不能吸收的弊病、采用针剂有利于药物全面吸收的新型戒毒药物。Another object of the present invention is to provide a new type of detoxification drug that avoids the disadvantages of vomiting and non-absorption of drugs by addicts after taking the drug, and uses injections to facilitate the comprehensive absorption of drugs.
本发明的目的可通过如下措施来实现:The purpose of the present invention can be achieved through the following measures:
一种新型戒毒药物由含有下述重量百分含量的原料按常规制剂方法制成药剂:薰倒牛1-100%、唐古特莨菪0-50%、镰形棘豆0-50%、羌活0-20%、半夏0-20%。A new type of drug detoxification drug is made from the following raw materials in the following weight percentages according to the conventional preparation method: 1-100% smoked beef, 0-50% scopolamine tangutate, 0-50% Oxytropis falciparum, 0-50% notopterygium -20%, pinellia 0-20%.
本发明的目的还可通过如下措施来实现:The object of the present invention can also be achieved by the following measures:
一种新型戒毒药物的制备方法包括下述步骤:(1)将唐古特茛菪、镰形棘豆和半夏粉碎后,采用常规醇提工艺提取得到提取物;往提取物中加入盐酸将浓缩物溶解,过滤后滤液调PH值为8-11,再用氯仿与上述滤液混合后进行萃取,再用盐酸自氯仿中提取生物碱,再将酸溶液中和,然后用乙醚进行萃取,回收乙醚得生物碱混合物A;(2)将薰倒牛、羌活粉碎后用乙醇煮沸提取3次,提取时间依次为3、2、1小时,各次的原料与乙醇的重量比为1∶8,1∶6,1∶4,合并3次提取液,取上清液回收乙醇,将提取液水溶后过大孔吸附树脂,再用水洗脱,蒸发洗脱液得薰倒牛碱;再用酒精洗脱大孔吸附树脂,得洗脱液,回收酒精得羌活有效部位;将薰倒牛碱和羌活有效部位混合得提取物B;(3)将提取物A、B混合常规制剂工艺制成药剂。A preparation method of a new drug detoxification drug comprises the following steps: (1) After pulverizing tangutate scorpion, Oxytropis falciparum and pinellia, extracting by conventional alcohol extraction process to obtain the extract; adding hydrochloric acid to the extract to concentrate After filtering, the filtrate is adjusted to a pH value of 8-11, and then mixed with chloroform and the above filtrate for extraction, and then the alkaloid is extracted from the chloroform with hydrochloric acid, then the acid solution is neutralized, and then extracted with ether, and the ether is recovered Obtain the alkaloid mixture A; (2) grind the smoked cow and notopterygium and extract by boiling with ethanol for 3 times, the extraction time is 3, 2, and 1 hour successively, and the weight ratio of each raw material to ethanol is 1:8, 1 : 6, 1: 4, combine the extracts for 3 times, take the supernatant to reclaim ethanol, dissolve the extract in water, pass it through the macroporous adsorption resin, then elute with water, evaporate the eluent to get lavonine; wash with alcohol Remove macroporous adsorption resin to obtain eluent, recover alcohol to obtain notopterygium effective part; mix funidoxine and notopterygium effective part to obtain extract B; (3) mix extract A and B with conventional preparation process to make medicament.
本发明的另一目的还可通过如下措施来实现:Another object of the present invention can also be achieved through the following measures:
一种新型戒毒药物可为针剂。A new type of detoxification drug can be an injection.
本发明相比现有技术具有如下优点:Compared with the prior art, the present invention has the following advantages:
1、本发明采用藏药薰倒牛(藏文称“明见赛保”)为主,利用薰倒牛碱与吗啡受体立体性结合及其抗胆碱和抗组胺等作用,可使中枢和外周症状消除,完全达到控制戒断症状的治疗目的。1. The present invention adopts the Tibetan medicine lavaniubine (Tibetan is called "Mingjian Saibao") as main, and utilizes lavenderine to combine with morphine receptors stereoscopically and its effects such as anticholinergic and antihistamine, which can make The central and peripheral symptoms are eliminated, and the therapeutic purpose of controlling withdrawal symptoms is fully achieved.
2、本发明的配伍中还可加入唐古特莨菪,其有效成分为莨菪碱,因而本发明具有良好的受体阻滞和镇痛作用。另本发明还添加镰形棘豆、羌活和半夏,因而本发明具有疏散、止痛、镇痉作用。2. Scopolamine tangutate can also be added to the compatibility of the present invention, and its active ingredient is hyoscyamine, so the present invention has good receptor blocking and analgesic effects. In addition, the present invention also adds Oxytropis falciparum, Notopterygium and Pinellia, so the present invention has evacuation, pain relief and antispasmodic effects.
3、本发明不含吗啡样物质,是一种非阿片类不成瘾药物,对患者不形成新的依赖。3. The present invention does not contain morphine-like substances, is a non-opioid non-addictive drug, and does not form new dependence on patients.
4、本发明经108例临床观察,肌注10分钟后即可起药效,三日后可完全解除戒断症状,而不形成新的依赖,五日后完全脱瘾(尿检吗啡转阴),因而本发明解除戒断症状完全、快效、安全。4, the present invention is through clinical observation of 108 cases, can play drug effect after intramuscular injection 10 minutes, can remove withdrawal symptom completely after three days, and does not form new dependence, completely withdraw from addiction (urine test morphine turns negative) after five days, thus The invention relieves withdrawal symptoms completely, quickly and safely.
5、本发明优选制成针剂,这种制剂可有利于药物吸收全面、迅速,对伴有恶心、呕吐、腹泄腹胀戒断症状的成瘾者,避免了口服药物后呕吐,药物不能吸收的弊病。经临床验证,其注射液疗程短,治疗期为3-4-天有效率为100%。在治疗结束后,戒断症状基本消失,躯体健康状况好转,渴求、焦虑、失眠三大症状总分小于10,尿液微量吗啡检测阴性为疗效显著,70%患者5天转阴,30%患者7天转阴,明显优于凯尔丁对照组(10天转阴)。5. The present invention is preferably prepared as an injection. This preparation can help the drug to be absorbed comprehensively and rapidly. For addicts with nausea, vomiting, diarrhea and abdominal distension withdrawal symptoms, it can avoid vomiting after oral administration of the drug and the drug cannot be absorbed. ills. It has been clinically verified that its injection has a short course of treatment, and the treatment period is 3-4 days, and the effective rate is 100%. After the treatment, the withdrawal symptoms basically disappeared, the physical health improved, the total score of the three major symptoms of craving, anxiety, and insomnia was less than 10, and the urine trace morphine test was negative, which indicated a significant curative effect. 70% of the patients turned negative within 5 days, and 30% of the patients It turned cloudy in 7 days, which was obviously better than that of the Keerding control group (turned cloudy in 10 days).
本发明还将结合实施例作进一步详述:The present invention will also be described in further detail in conjunction with embodiment:
实施例一:Embodiment one:
一种新型戒毒药物由含有下述重量百分含量的原料按常规制剂方法制成药剂:薰倒牛50%、唐古特莨菪25%、镰形棘豆10%、羌活7%、半夏8%。A new type of detoxification drug is made from the following raw materials according to the conventional preparation method: 50% smoked cow, 25% scopolamine tangutate, 10% Oxytropis falciparum, 7% notopterygium, 8% pinellia .
新型戒毒药物的制备方法包括下述步骤:(1)将唐古特莨菪、镰形棘豆和半夏按配方中的重量百分含量称取粉碎后,加等量的90%的乙醇湿润后,置渗漉筒中放置过夜,第二天以90%的乙醇渗漉,待渗漉液为原料的10倍时止,合并渗漉液,回收乙醇,得到提取物;往提取物中加入%的盐酸将浓缩物溶解,过滤后滤液调PH值为9,再用氯仿与上述滤液混合后进行萃取,再用5%的盐酸自氯仿中提取生物碱,再将酸溶液中和,然后用乙醚进行萃取,回收乙醚得生物碱混合物A;(2)将薰倒牛、羌活粉碎后用乙醇煮沸提取3次,提取时间依次为3、2、1小时,各次的原料与乙醇的重量比为1∶8,1∶6,1∶4,合并3次提取液,取上清液回收乙醇,将提取液水溶后过大孔吸附树脂,再用水洗脱用水量为树脂体积的2倍,蒸发洗脱液得薰倒牛碱;再用酒精洗脱大孔吸附树脂,得洗脱液,回收酒精得羌活有效部位;将薰倒牛碱和羌活有效部位混合得提取物B;(3)将提取物A、B混合常规制剂工艺制成药剂。优选制成针剂。本发明的药剂以薰倒牛碱N-3-甲基-2-丁烯基脲为质量控制标准,每次服用量含薰倒牛碱为15-40mg,每天为3次。The preparation method of the novel detoxification drug comprises the following steps: (1) weighing and pulverizing scopolamine tangutata, Oxytropis falciparum and pinellia according to the weight percentage in the formula, adding an equal amount of 90% ethanol to moisten, Place it in the percolation cylinder overnight, and percolate with 90% ethanol the next day. When the percolation liquid is 10 times that of the raw material, combine the percolation liquid, recover ethanol, and obtain the extract; add 90% hydrochloric acid to the extract Dissolve the concentrate, filter and adjust the pH value of the filtrate to 9, then mix the filtrate with chloroform and extract, then use 5% hydrochloric acid to extract the alkaloid from the chloroform, neutralize the acid solution, and then extract with ether , reclaim ether to obtain alkaloid mixture A; (2) grind the smoked cow and notopterygium and extract by boiling with ethanol 3 times, the extraction time is 3, 2, and 1 hour successively, and the weight ratio of each raw material to ethanol is 1: 8, 1:6, 1:4, combine the extracts for 3 times, take the supernatant to recover ethanol, dissolve the extract in water, pass through the macroporous resin, and then elute with water. liquid to obtain fubaniuine; then elute the macroporous adsorption resin with alcohol to obtain the eluent, and recover the alcohol to obtain the effective part of notopterygium; mix furnadoxine and the effective part of notopterygium to obtain extract B; (3) extract A and B are mixed with conventional preparation technology to make medicament. It is preferably prepared as an injection. The medicament of the present invention takes danidine N-3-methyl-2-butenyl urea as the quality control standard, and the dose of danidine contained in each dose is 15-40 mg, 3 times a day.
实施例二:Embodiment two:
一种新型戒毒药物由含有下述重量百分含量的原料按常规制剂方法制成药剂:薰倒牛100%。A new type of detoxification drug is made of raw materials containing the following weight percentages according to a conventional preparation method: 100% smoked cattle.
其制备方法与例一同,其原料仅为薰倒牛。Its preparation method is the same as the example, and its raw material is only smoked beef.
实施例三:Embodiment three:
一种新型戒毒药物由含有下述重量百分含量的原料按常规制剂方法制成药剂:薰倒牛50%、唐古特莨菪50%。A novel detoxification drug is prepared from raw materials containing the following percentages by weight according to a conventional preparation method: 50% smoked bull and 50% scopolamine tangut.
其制备方法与例一同,其原料仅为薰倒牛、唐古特莨菪。Its preparation method is the same as the example, and its raw materials are only smoked beef and tangut scopolamine.
实施例四:Embodiment four:
一种新型戒毒药物由含有下述重量百分台量的原料按常规制剂方法制成药剂:薰倒牛75%、镰形棘豆25%。A new drug detoxification drug is made of raw materials containing the following weight percentages according to a conventional preparation method: 75% of smoked beef and 25% of Oxytropis falciparum.
其制备方法与例一同,其原料仅为薰倒牛、镰形棘豆。Its preparation method is the same as the example, and its raw materials are only smoked beef and Oxytropis falciparum.
实施例五:Embodiment five:
一种新型戒毒药物由含有下述重量百分含量的原料按常规制剂方法制成药剂:薰倒牛40%、镰形棘豆40%、羌活20%。A new type of detoxification drug is made from raw materials containing the following weight percentages according to a conventional preparation method: 40% smoked beef, 40% Oxytropis falciparum and 20% notopterygium.
其制备方法与例一同,其原料仅为薰倒牛、镰形棘豆、羌活。Its preparation method is the same as in the example, and its raw materials are only smoked cattle, Oxytropis falciparum and notopterygium.
实施例六:Embodiment six:
一种新型戒毒药物由含有下述重量百分含量的原料按常规制剂方法制成药剂:薰倒牛4%、镰形棘豆6%、唐古特莨菪50%、羌活20%、半夏20%。A new type of detoxification drug is made from the following raw materials in the following weight percentages according to the conventional preparation method: 4% smoked cow, 6% Oxytropis falciparum, 50% scopolamine tangutate, 20% notopterygium, 20% pinellia .
其制备方法与例一同。Its preparation method is the same as the examples.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99115916A CN1090026C (en) | 1999-11-11 | 1999-11-11 | Novel medicine for stopping narcotic taking and preparation process thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99115916A CN1090026C (en) | 1999-11-11 | 1999-11-11 | Novel medicine for stopping narcotic taking and preparation process thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1295853A CN1295853A (en) | 2001-05-23 |
| CN1090026C true CN1090026C (en) | 2002-09-04 |
Family
ID=5278805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99115916A Expired - Fee Related CN1090026C (en) | 1999-11-11 | 1999-11-11 | Novel medicine for stopping narcotic taking and preparation process thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1090026C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0501655D0 (en) * | 2005-01-26 | 2005-03-02 | Veritron Ltd | Therapeutic use |
| CN103041034A (en) * | 2013-01-13 | 2013-04-17 | 刘传祥 | Preparation method of tangut anisodum extract |
| CN104523777B (en) * | 2014-12-16 | 2018-07-31 | 光明乳业股份有限公司 | One kind smoking the extractive of general flavone of falling ox, its extracting method and purposes |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1207300A (en) * | 1997-07-31 | 1999-02-10 | 尹大良 | Medicine for giving up drug |
| CN1223874A (en) * | 1998-01-23 | 1999-07-28 | 中国科学院西北高原生物研究所 | Medicine for abstaining from drug and preparing process thereof |
-
1999
- 1999-11-11 CN CN99115916A patent/CN1090026C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1207300A (en) * | 1997-07-31 | 1999-02-10 | 尹大良 | Medicine for giving up drug |
| CN1223874A (en) * | 1998-01-23 | 1999-07-28 | 中国科学院西北高原生物研究所 | Medicine for abstaining from drug and preparing process thereof |
Non-Patent Citations (4)
| Title |
|---|
| 《中级医刊》1985年第20卷第12期 1985.1.1 汪宗俊;"莨菪类药物的新用途" * |
| 《植物杂志》1989年第2期 1989.1.1 于荣敏等;"棘豆漫笔" * |
| 《药学学报》1995年第30卷第3期 1995.1.1 张晓峰等;"藏药薰倒牛的活性物质研究";《植物杂志》1989年第2期 1989.1.1 于荣敏等;"棘豆漫笔";《中级医刊》1985年第20卷第12期 1985.1.1 汪宗俊;"莨菪类药物的新用途" * |
| 《药学学报》1995年第30卷第3期 1995.1.1 张晓峰等;"藏药薰倒牛的活性物质研究" * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1295853A (en) | 2001-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2271059A (en) | Pharmaceutical compositions comprising aconitane derivatives | |
| CN1726990A (en) | Application and the extraction process of natural Chinese medicinal herb in drug-breaking medicine that contains effective alkaloid | |
| KR19980014498A (en) | Rich-sulfur combination preparation | |
| CN1090026C (en) | Novel medicine for stopping narcotic taking and preparation process thereof | |
| CN104758445A (en) | Tobacco leaf extract, uses thereof in treatment of dependence | |
| CN102008594B (en) | Traditional Chinese medicine preparation used for drug abstention treatment and preparation method thereof | |
| CN1052885C (en) | Chinese medicine herbs for giving off drug of opium | |
| CN1295852A (en) | Medicinal composition for stopping narcotic taking and preparation process thereof | |
| CN1840043A (en) | A kind of pharmaceutical composition for treating depression and its preparation method and application | |
| CN1064545C (en) | Medicine for abstaining from drug and preparing process thereof | |
| CN1061264C (en) | Pure Chinese medicine for stopping drugs and its prepn. tech. | |
| CN1081042C (en) | Traditional Chinese medicinal composition for stopping drug taking and preparation process thereof | |
| CN101972251B (en) | Application of rhynchophylline in the preparation of detoxification drugs | |
| CN1281269C (en) | Chinese medicine preparation for quickly-stopping addiction and curing abstinence syndrome, its preparation method and application | |
| CN105726779A (en) | Traditional Chinese medicine composition for rehabilitation and preparation method thereof | |
| KR101817761B1 (en) | Composition containing acontitie tuber and sulfurprecipitatum | |
| CN1298374C (en) | Chinese medicine for giving up drugs | |
| CN110179889B (en) | A kind of traditional Chinese medicine composition for quitting heroin addiction and preparation method thereof | |
| US7288269B2 (en) | Asafetida extract as medicine for abstinence of drugs | |
| CN1250274C (en) | Medicine for abstinence of drugs and rehabilitation, and preparing process thereof | |
| CN101156912B (en) | A compound recipe traditional Chinese medicine composition and its purpose | |
| CN1190207C (en) | Medicine for withdrawal of drug addiction and preparing process thereof | |
| CN1357359A (en) | Drug addiction stopping machine medicine and its prepn | |
| CN116036197A (en) | A Chinese medicinal concentrated pill for treating drug addiction | |
| CN1636579A (en) | Hypoglycemic Chinese medicine prepn and its production process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |